Global Point-of-care Testing Growth Opportunities Updated Research Available
Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem
15-Nov-2023
North America
Market Research
K973-01-00-00-00
HC_2023_319
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology
testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.
In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid
amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance
testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control
plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.
In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and
small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.
A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization
of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.
Author: Amartya Bose
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Scope of Analysis (continued)
Segmentation—Test Type
Segmentation—Care Continuum
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Growth Restraints (continued)
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Test Type
Revenue Forecast by Region
Revenue Forecast by Care Continuum
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Pricing Trends and Forecast Analysis
Competitive Environment
POCT Across Different Therapy Areas
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Competitor Matrix—Therapy Areas
Competitor Matrix—Technology Mapping
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Immunochemistry POCT
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Molecular POCT Therapy Areas
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Opportunity 1: Molecular POCT
Growth Opportunity 1: Molecular POCT (continued)
Growth Opportunity 2: Multiplexing
Growth Opportunity 2: Multiplexing (continued)
Growth Opportunity 3: STI POCT
Growth Opportunity 3: STI POCT (continued)
Growth Opportunity 4: AMR POCT
Growth Opportunity 4: AMR POCT (continued)
Growth Opportunity 5: Routine POCT
Growth Opportunity 5: Routine POCT (continued)
Growth Opportunity 6: Smartphone POCT
Growth Opportunity 6: Smartphone POCT (continued)
Future of POCT in Care Continuum
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
- POCT Industry: Growth Metrics, Global, 2023
- POCT Industry: Growth Drivers, Global, 2024–2028
- POCT Industry: Growth Restraints, Global, 2024–2028
- POCT Industry: Revenue Forecast, Global, 2023–2028
- POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028
- POCT Industry: Revenue Forecast by Region, 2023–2028
- POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028
- POCT Industry: Revenue Share of Top Participants, Global, 2023
- POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023
- Immunochemistry POCT: Growth Metrics, Global, 2023
- Immunochemistry POCT: Revenue Forecast, Global, 2023–2028
- Immunochemistry POCT: Revenue Forecast by Region, 2023–2028
- Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028
- Molecular POCT: Growth Metrics, Global, 2023
- Molecular POCT: Revenue Forecast, Global, 2023–2028
- Molecular POCT: Revenue Forecast by Region, 2023–2028
- Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
19 Nov 2026 | Global | Technology Research
Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms
Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.